nilutamide

Known as: 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione, 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin, Nilutamida 
A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2017
05101519792017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Rice seedlings cv. Khao Dawk Mali 105 (salt-sensitive), Luang Anan (moderately salt-tolerant) and Pokkali (salt-tolerant) were… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
PURPOSE We reported previously the first randomized study of any kind in patients with nonmetastatic, castrate-resistant prostate… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2005
2005
Salt-induced changes in protein synthesis in leaf sheaths of the Thai rice cv. Leaung Anan were investigated using one… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2003
2003
PURPOSE We investigate the prostate specific antigen (PSA) response rate with nilutamide as a second line hormonal agent in… (More)
Is this relevant?
2001
2001
OBJECTIVES To study the ability of nilutamide to induce prostate-specific antigen (PSA) responses in patients with hormone… (More)
Is this relevant?
1997
1997
Antiandrogens are combined with medical or surgical castration to achieve total androgen blockade in metastatic prostate cancer… (More)
Is this relevant?
1993
1993
The efficacy and tolerance of the nonsteroidal antiandrogen nilutamide in the treatment of prostatic cancer were studied in a… (More)
Is this relevant?
1991
1991
A total of 26 previously untreated patients with metastatic carcinoma of the prostate received the pure nonsteroidal antiandrogen… (More)
Is this relevant?
1990
1990
A randomized double-blind trial in patients with disseminated, previously untreated prostate cancer (Stage D2) was conducted in… (More)
Is this relevant?
1989
1989
Gonadotropin-releasing hormone (GnRH) analogues administered for the treatment of advanced prostatic cancer induce a transient… (More)
Is this relevant?